Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2

Artursson, 1996, Caco-2 monolayers in experimental and theoretical predictions of drug transport, Adv. Drug Del. Rev., 22, 67, 10.1016/S0169-409X(96)00415-2 Augustinjns, 1993, Evidence of a polarized efflux system in Caco-2 cells capable of modulating cyclosporine A transport, Biochem. Biophys. Res. Commun., 197, 360, 10.1006/bbrc.1993.2487 Bailey, 1996, The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development, Adv. Drug Del. Rev., 22, 85, 10.1016/S0169-409X(96)00416-4 Barr, 1996, Pharmacokinetics and mechanisms of drug absorption in drug discovery, preclinical and Phase I studies, 1.6.1 Chan, 1996, Absorption of Cam-2445, an NK1 neurokinin receptor antagonist: in vivo, in situ, and in vitro evaluations, J. Pharm. Sci., 85, 253, 10.1021/js9503338 Hosoya, 1996, Age dependent expression of P-glycoprotein gp 170 in Caco-2 cell monolayers, Pharm. Res., 13, 885, 10.1023/A:1016005212640 Hunter, 1993, Functional expression of p-glycoprotein in the apical membranes of human intestinal Caco-2 cells, J. Biol. Chem., 268, 14991, 10.1016/S0021-9258(18)82429-2 Irollo, 1987, Dissociation and association rate constants changes following bilirubin binding affinity decreases, Dev. Pharmacol. Ther., 10, 436, 10.1159/000457775 Krishna, 1999, Higher-throughput P-glycoprotein assay for screening compounds in drug discovery, Pharm. Sci., 1, S265 Mintenig, 1993, Specific inhibitors distinguish the chloride channel and drug transporter functions associated with the human multidrug resistance p-glycoprotein, Receptors Channels, 1, 305 Nerurkar, 1996, The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system, Pharm. Res., 13, 528, 10.1023/A:1016033702220 Nicklin, 1992, Permeable support type influences the transport of compounds across Caco-2 cells, Int. J. Pharm., 83, 197, 10.1016/0378-5173(82)90023-0 Okumu, 1997, Effect of restricted conformational flexibility on the permeation of model hexapeptides across Caco-2 cell monolayers, Pharm. Res., 14, 169, 10.1023/A:1012092409216 Rubas, 1993, Comparison of the permeability characteristic of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption, Pharm. Res., 10, 113, 10.1023/A:1018937416447 Taveras, 1999, Identification of pharmacokinetically stable 3,10-dibromo-8-chlorobenzocycloheptapyridine farensyl protein transferase inhibitors with potent enzyme and cellular activities, J. Med. Chem., 42, 2651, 10.1021/jm990059k Taylor, 1997, Intestinal absorption screening of mixtures from combinatorial libraries in the Caco-2 model, Pharm. Res., 14, 572, 10.1023/A:1012140709158 Wils, 1994, High lipophilicity decreases drug transport across intestinal epithelial cells, J Pharmacol. Exp. Ther., 269, 654 Yee, 1996, In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man- fact or myth, Pharm. Res., 14, 763, 10.1023/A:1012102522787